Skip to main content
Premium Trial:

Request an Annual Quote

TissueInformatics Pairs With Ohio Startup For Obesity, Diabetes Research

NEW YORK, April 26-DiAthegen and TissueInformatics said today that they would be working together to find new drug targets and diagnostics for obesity and type II diabetes.


The research agreement, slated to last five years, seeks to correlate gene expression changes to histological changes during the initiation and progression of type II diabetes. The studies will include both animal and human tissues.


DiAthegen will supply animal modeling, molecular biology and transgenic animal services to the cooperative effort.


TissueInformatics will provide automated tissue imaging, tissue analysis and gene expression capabilities.


The companies did not disclose financial details of the arrangement.


DiAthegen, an Athens, Ohio startup, seeks to develop new diagnostics and therapeutics for obesity, diabetes and hyperinsulinemea through genomic and animal models.

The Scan

Sick Newborns Selected for WGS With Automated Pipeline

Researchers successfully prioritized infants with potential Mendelian conditions for whole-genome sequencing or rapid whole-genome sequencing, as they report in Genome Medicine.

Acne-Linked Loci Found Through GWAS Meta-Analysis

Researchers in the European Journal of Human Genetics find new and known acne vulgaris risk loci with a genome-wide association study and meta-analysis, highlighting hair follicle- and metabolic disease-related genes.

Retina Cell Loss Reversed by Prime Editing in Mouse Model of Retinitis Pigmentosa

A team from China turns to prime editing to correct a retinitis pigmentosa-causing mutation in the PDE6b gene in a mouse model of the progressive photoreceptor loss condition in the Journal of Experimental Medicine.

CRISPR Screens Reveal Heart Attack-Linked Gene

Researchers in PLOS Genetics have used CRISPR screens to home in on variants associated with coronary artery disease that affect vascular endothelial function.